================================================================================
UNITED STATES
SECURITIES AND EXCHANGE COMMISSION
WASHINGTON, D.C. 20549
----------
FORM 8-K/A
----------
CURRENT REPORT
PURSUANT TO SECTION 13 OR 15(d) OF THE
Securities Exchange Act of 1934
Date of Report (Date of earliest event reported): August 28, 2003
PHIBRO ANIMAL HEALTH CORPORATION
(Exact name of registrant as specified in its charter)
New York 333-64641 13-1840497
- ------------------------------- ---------------- ----------------------
(State or other jurisdiction of (Commission File (IRS Employer
incorporation) Number) Identification Number)
One Parker Plaza
Fort Lee, New Jersey 07024
---------------------------------------------------
(Address of principal executive offices) (Zip Code)
(201) 944-6020
----------------------------------------------------
(Registrant's telephone number, including area code)
================================================================================
Explanatory Note
This amended current report is being filed by Phibro Animal Health
Corporation (the "Company") in connection with its withdrawal of its application
for confidential treatment of certain portions of a Stock Purchase Agreement
dated as of August 14, 2003, between the Company and Cemex, Inc. (the "Stock
Purchase Agreement"). The Company's sole purpose for filing this current report
on Form 8-K/A is to file as an exhibit hereto an un-redacted copy of the Stock
Purchase Agreement that was previously filed in redacted form on a Form 8-K (SEC
File No. 333-64641), dated September 11, 2003. Pursuant to Rule 12b-15 under the
Securities and Exchange Act of 1934, the complete text of Item 7(c) as amended
is set forth below.
Item 7. Financial Statements and Exhibits
(c) Exhibits
Exhibit 1 Stock Purchase Agreement, dated as of August 14, 2003, between
Cemex, Inc. and Phibro Animal Health Corporation
2
SIGNATURES
Pursuant to the requirements of the Securities Exchange Act of 1934, the
Company has duly caused this report to be signed on its behalf by the
undersigned hereunto duly authorized.
PHIBRO ANIMAL HEALTH CORPORATION
By: /s/ Richard G. Johnson
-----------------------------
Richard G. Johnson,
Chief Financial Officer
Dated: June 2, 2004
3
Exhibit Index
Exhibit No. Description
Exhibit 1 Stock Purchase Agreement, dated as of August 14, 2003, between
Cemex, Inc. and Phibro Animal Health Corporation